Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 212-222-7 | CAS number: 770-35-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Two repeated dose dermal toxicity studies (14-days and 28-days) in rabbits are available for phenoxypropanol. Both studies have been conduced under GLP and are equivalent or similar to OECD guideline 410. For the oral route 3 GLP-studies according to OECD guidelines 407, 408 and 416 have been conducted in rats using drinking water administration of the test material.
Key value for chemical safety assessment
Repeated dose toxicity: via oral route - systemic effects
Endpoint conclusion
- Dose descriptor:
- NOAEL
- 146 mg/kg bw/day
- Study duration:
- subchronic
- Species:
- rat
Repeated dose toxicity: dermal - systemic effects
Endpoint conclusion
- Dose descriptor:
- NOAEL
- 1 000 mg/kg bw/day
- Study duration:
- subacute
- Species:
- rabbit
Additional information
Oral: In a 90-day drinking water study in rats concentrations of 500, 2000 and 6000 ppm have been used. At 500 ppm no substance related effects have been observed and at 2000 ppm the only effects observed were decreased body weight (less than 10%) and discoloration of urine. Therefore, the 2000 ppm (146 mg/kg bw/d) dose level is considered to be the NOAEL and will be used as critical dose descriptor to derive the DNEL.
This data is supported by the results of a 2 -generation reproductive toxicity study in rats and the 4 week range finder for this study, both conducted via drinking water administration of the test material. PPh was administered to two generations of rats (25/sex/group) in for 26 weeks at concentrations of 100, 1000, or 5000 ppm (equivalent to doses of 0, 11.3, 113, or 478 mg/kg-d) (this study is also discussed in section 7.8.1). Effects were seen only at the highest exposure concentration that manifested as reduced body weights and corresponding reduced food and water consumption. No clinical signs were evident during the course of exposure and no gross or histopathological lesions were seen at autopsy. The NOEL for this drinking water study with rats was 1000 ppm (113 mg/kg-d) and the LOAEL was 5000 ppm (478 mg/kg-day), based on body weight changes.
Dermal: two GLP-studies in rabbits are available for the dermal route of exposure. In a 28 -day study no systemic effects have been observed up to the limit dose of 1000 mg/kg bw/day. Mild dermal irritation characterized by slight hyperemia and moderate exfoliation was observed in the 1000 mg/kg/day animals. Slight exfoliation was observed in most of the 300 mg/kg/day animals (slight hyperemia was also present for females), while 100 mg/kg/day animals showed only very slight exfoliation. Therefore, the NOAEL for local effects is 100 mg/kg bw/day. This is supported by a 14 -day study where no systemic effects have been observed at the limit dose of 1000 mg/kg bw/day, but dermal irritation was evident at this dose level.
Inhalation: no studies via the inhalation route are available for PPh. However, based on the low vapor pressure of this material inhalation exposure is not considered to be relevant.
Repeated dose toxicity: via oral route - systemic effects (target organ) urogenital: kidneys
Justification for classification or non-classification
The no observed adverse effect levels for phenoxypropanol exceed the values triggering classification. Therefore no classification for prolonged exposure is required.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.